Alizapride is a dopamine Dâ‚‚ receptor antagonist active pharmaceutical ingredient supplied as a white to off-white crystalline powder for use in pharmaceutical formulations. It exerts its pharmacological activity by blocking central dopamine receptors in the chemoreceptor trigger zone, thereby suppressing the emetic response and supporting the control of nausea and vomiting.
Its targeted antiemetic action makes it suitable for incorporation into oral and parenteral dosage forms intended for the management of nausea and vomiting across various clinical settings. The API is packaged in double LDPE bags within HDPE drums or equivalent pharma-grade, moisture-protective containers to maintain stability under recommended storage conditions.
As a leading distribution partner, Molkem Chemicals ensures reliable supply of products aligned with industry quality standards and regulatory expectations. Each product is delivered as per agreed specifications, supported by standard documentation including COA, SDS, and TDS. If required, our technical team can provide additional stability data and regulatory assistance.
Global - English
Brazil - Portuguese
Thailand - Thai
Middle East - Arabic
Vietnam - Vietnamese
Spain - Spanish
Colombia - Spanish
Argentina - Spanish
